Lupin has received tentative approval from the US FDA for its generic version of an HIV drug, to be manufactured at its ...
The Duke of Sussex in a new short film to raise awareness of the the devastating impact of recent funding cuts ...
Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...
Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new HIV prevention drug in poor countries.
The two organisations have entered into separate agreements with Indian pharmaceutical companies to produce cheaper generic ...
Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs said today that they will sell generic versions of a new and highly ...
The twice-yearly drug has been hailed as a medical breakthrough that could change the course of the HIV epidemic. View on ...
Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may ...
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback